A systematic overview of radiation therapy effects in cervical cancer (cervix uteri)

被引:34
作者
Einhorn, N
Tropé, C
Ridderheim, M
Boman, K
Sorbe, B
Cavallin-Ståhl, E
机构
[1] Norwegian Radium Hosp, Dept Gynecol Oncol, NO-0310 Oslo, Norway
[2] Karolinska Hosp, Dept Oncol, Stockholm, Sweden
[3] Univ Hosp, Dept Gynecol Oncol, Lund, Sweden
[4] Univ Hosp, Dept Oncol, Umea, Sweden
[5] Orebro Med Ctr Hosp, Dept Oncol, Orebro, Sweden
[6] Univ Hosp, Dept Oncol, Lund, Sweden
关键词
D O I
10.1080/02841860310014660
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A systematic review of radiation therapy trials in several tumour types was performed by The Swedish Council of Technology Assessment in Health Care (SBU). The procedures for evaluation of the scientific literature are described separately (Acta Oncol 2003; 42: 357-365). This synthesis of the literature on radiation therapy for cervical cancer is based on data from 1 meta-analysis and 34 randomized trials. In total, 35 scientific articles are included, involving 7952 patients. The results were compared with those of a similar overview from 1996 including 34 024 patients. The conclusions reached can be summarized in these points: There are limited scientific data supporting that postoperative pelvic radiotherapy improves disease-free survival in early cervical cancer. No firm conclusion can be drawn. There is moderate scientific evidence that external beam radiotherapy combined with brachytherapy gives a similar disease-free and overall survival rate as radical hysterectomy in early cervical cancer. There is strong scientific evidence that concomitant radiochemotherapy improves disease-free and overall survival compared to radiotherapy alone in early cervical cancer. The NCI has recently published an announcement stating that cisplatin-based chemotherapy should be used concomitantly with radiotherapy in cervical cancer. No solid documentation for this statement can be found concerning locally advanced stages ( >IIB). There is a strong scientific evidence that cisplatin-based chemotherapy given concomitantly with radiotherapy is superior to concomitant chemotherapy with hydroxyurea. There is no scientific evidence to show that neoadjuvant chemotherapy followed by radiotherapy improves disease-free or overall survival compared to radiotherapy alone in patients with localized cervical cancer. There is moderate scientific evidence that high-dose-rate brachytherapy gives the same local control rate as low-dose-rate brachytherapy but with fewer rectal complications.
引用
收藏
页码:546 / 556
页数:11
相关论文
共 36 条
[1]  
Chatani M., 1994, Strahlentherapie und Onkologie, V170, P636
[2]  
Chatani M., 1995, Strahlentherapie und Onkologie, V171, P655
[3]   RANDOMIZED STUDY COMPARING CHEMOTHERAPY PLUS RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN FIGO STAGE-IIB-III CERVICAL-CARCINOMA [J].
CHIA, S ;
BRUZZONE, M ;
MERLINI, L ;
PRUZZI, P ;
ROSSO, R ;
FRANZONE, P ;
ORSATTI, M ;
VITALE, V ;
FOGLIA, G ;
ODICINO, F ;
RAGNI, N ;
RUGIATI, S ;
CONTE, P .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1994, 17 (04) :294-297
[4]   Adjuvant chemotherapy versus chemotherapy plus pelvic irradiation for high-risk cervical cancer patients after radical hysterectomy and pelvic lymphadenectomy (RH-PLND): A randomized phase III trial [J].
Curtin, JP ;
Hoskins, WJ ;
Venkatraman, ES ;
Almadrones, L ;
Podratz, KC ;
Long, H ;
Teneriello, M ;
Averette, H ;
Sevin, BU .
GYNECOLOGIC ONCOLOGY, 1996, 61 (01) :3-10
[5]   Carcinoma of the cervix and the use of hyperbaric oxygen with radiotherapy: a report of a randomised controlled trial [J].
Dische, S ;
Saunders, MI ;
Sealy, R ;
Werner, ID ;
Verma, N ;
Foy, C ;
Bentzen, SM .
RADIOTHERAPY AND ONCOLOGY, 1999, 53 (02) :93-98
[6]  
El-Baradie M., 1997, Strahlentherapie und Onkologie, V173, P155
[7]   Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis [J].
Green, JA ;
Kirwan, JM ;
Tierney, JF ;
Symonds, P ;
Fresco, L ;
Collingwood, M ;
Williams, CJ .
LANCET, 2001, 358 (9284) :781-786
[8]   Irradiation with or without misonidazole for patients with stages IIIB and IVA carcinoma of the cervix: Final results of RTOG 80-05 [J].
Grigsby, PW ;
Winter, K ;
Wasserman, TH ;
Marcial, V ;
Rotman, M ;
Cooper, J ;
Keys, H ;
Asbell, SO ;
Phillips, TL .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 44 (03) :513-517
[9]   ANALYSIS OF COMPLICATIONS IN A PROSPECTIVE RANDOMIZED TRIAL COMPARING 2 BRACHYTHERAPY LOW-DOSE RATES IN CERVICAL-CARCINOMA [J].
HAIEMEDER, C ;
KRAMAR, A ;
LAMBIN, P ;
LANCAR, R ;
SCALLIET, P ;
BOUZY, J ;
GERBAULET, A .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 29 (05) :953-960
[10]   Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma [J].
Keys, HM ;
Bundy, BN ;
Stehman, FB ;
Muderspach, LI ;
Chafe, WE ;
Suggs, CL ;
Walker, JL ;
Gersell, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (15) :1154-1161